Joseph K. Belanoff
2019
In 2019, Joseph K. Belanoff earned a total compensation of $5M as Chief Executive Officer and President at Corcept Therapeutics, a 21% decrease compared to previous year.
Compensation breakdown
| Bonus | $745,290 |
|---|---|
| Option Awards | $3,506,155 |
| Salary | $707,525 |
| Total | $4,958,970 |
Belanoff received $3.5M in option awards, accounting for 71% of the total pay in 2019.
Belanoff also received $745.3K in bonus and $707.5K in salary.
Rankings
In 2019, Joseph K. Belanoff's compensation ranked 2,222nd out of 13,971 executives tracked by ExecPay. In other words, Belanoff earned more than 84.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,222 out of 13,971 | 84th |
Division Manufacturing | 806 out of 5,695 | 86th |
Major group Chemicals And Allied Products | 255 out of 2,194 | 88th |
Industry group Drugs | 206 out of 1,880 | 89th |
Industry Pharmaceutical Preparations | 150 out of 1,392 | 89th |
Source: SEC filing on April 27, 2020.
Belanoff's colleagues
We found three more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2019.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019